Company intelligence / Profile preview

Store-a-Cell

Ownership: Private
Development stage: Other

Overview

Store-a-Cell is a biotechnology company specializing in the long-term cryopreservation and storage of human cells for future medical use. The company provides services for individuals to bank their own healthy cells, such as dental pulp stem cells or other adult stem cells, to be used in potential future regenerative medicine treatments. By preserving cells while a patient is young or healthy, Store-a-Cell aims to provide a biological insurance policy for personalized cell-based therapies. Their business model focuses on the collection, processing, and secure cryogenic storage of these cellular assets.

Modalities: Cell therapyStem cell therapy
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Store-a-Cell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Store-a-Cell.

Explore the full profile